Therefore, our findings further support the potential of CRP as an etiological biomarker for AIS, suggesting that AIS patients with elevated CRP levels in thrombus are more likely to have CE as the underlying etiology. The gene discussed is CRP; the disease is androgen insensitivity syndrome.